Hypomethylation of VTRNA2-1 promoter predicts adverse outcomes in peripheral artery disease. - Tsai ML; Huang YC; Ho MY; Yeh JK; Chen CC; Chia CY; Fan WL; Hsieh IC; Tsai CN; Wang CY (Clinical epigenetics, 2026)